Application Sponsors
ANDA 212705 | AMNEAL PHARMS LLC | |
Marketing Status
Application Products
001 | SUSPENSION;ORAL | 25MG/ML | 0 | NAPROXEN | NAPROXEN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-07-31 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
AMNEAL PHARMS LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 212705
[companyName] => AMNEAL PHARMS LLC
[docInserts] => ["",""]
[products] => [{"drugName":"NAPROXEN","activeIngredients":"NAPROXEN","strength":"25MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/31\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-07-31
)
)